UnknownNot Applicable

Registry Study for the Observation of Patients With ESUS/Cryptogenic Stroke

Germany750 participantsStarted 2018-01-01

Plain-language summary

Up to know, there is no clear diagnostic and therapeutic pathway for patients with embolic stroke of undetermined source (ESUS). This prospective registry study, which follows up adult ESUS patients for 36 months, is intended to provide important data for the detection of an individual approach in ESUS patients based on a structured diagnostic and therapeutic pathway.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Embolic stroke of undetermined source or cryptogenic stroke; defined as: non-lacunar brain infarction without proximal arterial stenosis or cardioembolic source or other etiology (e.g. vasculitis, cervical artery dissection) * ≥18 years * written consent to participation in the study register by the patient or the legal guardian or authorised representative at the time of inclusion in the study

What they're measuring

Recurrence of stroke

Timeframe: 36 months

Trial details

NCT IDNCT03820375

SponsorLudwig-Maximilians - University of Munich

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-01-01

Contact for this trial

Lars Kellert, MD

0049 (0) 89 4400 73962 Lars.Kellert@med.uni-muenchen.de

View on ClinicalTrials.gov More Embolic Stroke of Undetermined Source trials